Insider · CIK 0001296907

Jones Elaine V

Reports to the SEC for 9 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001296907

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,340 sh	—	—	2,340
2026-06-17	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+59K sh	—	—	59,000
2025-06-20	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.7K sh	—	—	18,700
2025-06-11	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2025-04-04	Gritstone bio, Inc.Stock Option (Right to Buy)J Other	Director	JOther	−15.9K sh	—	—	0
2025-04-04	Gritstone bio, Inc.Stock Option (Right to Buy)J Other	Director	JOther	−51.8K sh	—	—	0
2025-04-04	Gritstone bio, Inc.Stock Option (Right to Buy)J Other	Director	JOther	−51.8K sh	—	—	0
2025-04-04	Gritstone bio, Inc.Stcok Option (right to buy)J Other	Director	JOther	−19K sh	—	—	0
2025-04-04	Gritstone bio, Inc.Stock Option (Right to Buy)J Other	Director	JOther	−19K sh	—	—	0
2025-04-04	Gritstone bio, Inc.Stock Option (Right to Buy)J Other	Director	JOther	−12.5K sh	—	—	0
2024-06-20	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.7K sh	—	—	18,700
2024-06-17	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+51.8K sh	—	—	51,800
2024-05-15	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2023-06-22	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2023-06-16	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+51.8K sh	—	—	51,800
2023-06-14	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-03-29	CTMXCytomX Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$1.55	+$7,750	5,142
2022-06-23	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2022-06-17	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2022-06-15	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-06-24	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2021-06-18	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2021-06-16	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-18	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2020-06-17	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-11	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,250
2019-09-12	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.9K sh	—	—	15,942
2019-06-19	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2019-06-13	NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2019-05-01	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2015-09-30	SYBXSYNLOGIC, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,200 sh	—	—	7,200
2007-11-29	GYREGYRE THERAPEUTICS, INC.X Exercise of In-Money	Director	XExercise of In-Money	+20K sh	$9.37	+$187K	20,000
2007-11-29	GYREGYRE THERAPEUTICS, INC.X Exercise of In-Money	Director	XExercise of In-Money	+7,500 sh	$9.37	+$70.3K	27,500
2007-11-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−20K sh	—	—	0
2007-11-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−7,500 sh	—	—	0
2007-05-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−4,333 sh	—	—	0
2007-05-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−1,000 sh	—	—	0
2007-05-29	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,333 sh	$0.07	+$399.975	1,516,216

Recent filings

Accepted (ET)
Jun 224
Jones Elaine V0001610717-26-000274
SEC(opens sec.gov)
Jun 224
Jones Elaine V0000905148-26-003045
SEC(opens sec.gov)
Jun 244
Jones Elaine V0000905148-25-002245
SEC(opens sec.gov)
Jun 134
Jones Elaine V0001610717-25-000211
SEC(opens sec.gov)
Apr 84
Jones Elaine V0001415889-25-010438
SEC(opens sec.gov)
Jun 214
Jones Elaine V0000905148-24-001767
SEC(opens sec.gov)
Jun 204
Jones Elaine V0001415889-24-017701
SEC(opens sec.gov)
May 174
Jones Elaine V0001610717-24-000244
SEC(opens sec.gov)
Jun 234
Jones Elaine V0001140361-23-031189
SEC(opens sec.gov)
Jun 214
Jones Elaine V0000899243-23-016161
SEC(opens sec.gov)
Jun 164
Jones Elaine V0001610717-23-000178
SEC(opens sec.gov)
Mar 314
Jones Elaine V0001140361-23-015503
SEC(opens sec.gov)
Jun 244
Jones Elaine V0001567619-22-013367
SEC(opens sec.gov)
Jun 224
Jones Elaine V0001567619-22-013258
SEC(opens sec.gov)
Jun 174
Jones Elaine V0001567619-22-013070
SEC(opens sec.gov)

Companies

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080